Osteoarthritis Therapeutics Market to reach USD 10.1 billion by 2024, at a CAGR of 8.1%
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
Global osteoarthritis therapeutics market is expected to grow...